- Home
- ESSA vs FENC Comparison
ESSA vs FENC Comparison
Compare ESSA & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESSA
- FENC
- Stock Information
- Founded
- ESSA 1916
- FENC 1996
- Country
- ESSA United States
- FENC United States
- Employees
- ESSA N/A
- FENC N/A
- Industry
- ESSA Banks
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ESSA Finance
- FENC Health Care
- Exchange
- ESSA Nasdaq
- FENC Nasdaq
- Market Cap
- ESSA 195.3M
- FENC 156.9M
- IPO Year
- ESSA N/A
- FENC 2001
- Fundamental
- Price
- ESSA $21.23
- FENC $6.65
- Analyst Decision
- ESSA
- FENC Strong Buy
- Analyst Count
- ESSA 0
- FENC 2
- Target Price
- ESSA N/A
- FENC $14.00
- AVG Volume (30 Days)
- ESSA 43.7K
- FENC 58.2K
- Earning Date
- ESSA 01-29-2025
- FENC 03-20-2025
- Dividend Yield
- ESSA 2.86%
- FENC N/A
- EPS Growth
- ESSA N/A
- FENC N/A
- EPS
- ESSA 1.74
- FENC N/A
- Revenue
- ESSA $67,430,000.00
- FENC $49,348,000.00
- Revenue This Year
- ESSA N/A
- FENC $170.43
- Revenue Next Year
- ESSA N/A
- FENC $6.70
- P/E Ratio
- ESSA $11.94
- FENC N/A
- Revenue Growth
- ESSA N/A
- FENC 278.09
- 52 Week Low
- ESSA $15.29
- FENC $3.96
- 52 Week High
- ESSA $21.62
- FENC $11.49
- Technical
- Relative Strength Index (RSI)
- ESSA 58.98
- FENC 66.40
- Support Level
- ESSA $20.77
- FENC $6.30
- Resistance Level
- ESSA $21.62
- FENC $6.64
- Average True Range (ATR)
- ESSA 0.51
- FENC 0.29
- MACD
- ESSA 0.10
- FENC 0.06
- Stochastic Oscillator
- ESSA 68.66
- FENC 90.23
About ESSA ESSA Bancorp Inc.
ESSA Bancorp Inc is a holding company, engaged in accepting deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, in residential first mortgage loans (including construction mortgage loans), commercial real estate loans, home equity loans and lines of credit and commercial and industrial loans. The company offers a variety of deposit accounts, including checking, savings and certificates of deposit. The company also offers asset management and trust services and investment services. The company also offers insurance benefit consulting services through its wholly-owned subsidiary, ESSA Advisory Services, LLC.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.